Optimum level of NEDD4 and its interaction with nsP3 are crucial to facilitate efficient Chikungunya virus (CHIKV) infection. [PDF]
J Gen VirolChikungunya is a febrile infection caused by the Chikungunya virus (CHIKV), an alphavirus which has emerged as a serious public health problem globally. Despite extensive research, our understanding of different host factors facilitating effective CHIKV infection is not clear yet. NEDD4, a member of the E3 ubiquitin ligase, is one such protein.
Verma S +7 more
europepmc +3 more sources
Analysis of Humoral Immune Responses in Chikungunya Virus (CHIKV)-Infected Patients and Individuals Vaccinated with a Candidate CHIKV Vaccine [PDF]
The Journal of Infectious Diseases, 2020 Abstract Background Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that causes severe flu-like symptoms. The acute symptoms disappear after 1 week, but chronic arthralgia can persist for years.
Lisa Henß +7 more
openalex +5 more sources
Virology Reports, 2021 AbstractConcomitant circulation of dengue and chikungunya viruses has been sporadically reported and needs to be individually diagnosed. Several sensitive molecular diagnostics are currently deployed for the diagnosis of both DENV and CHIKV, it is very difficult to delineate the two viral infections based on symptomology, as both share similar clinical
Rohit Sagar +9 more
openalex +3 more sources
In silico analysis of Chikungunya virus (CHIKV), a mosquito-borne alphavirus
African Journal of Microbiology Research, 2017 Chikungunya virus (CHIKV) is a mosquito-borne alpha virus, which belongs to the family, Togaviridae. This virus is known to cause an acute onset of high fever, severe arthralgia and rash, and is usually accompanied by headache and severe joint pain.
Hassuzana Khalil +2 more
openalex +3 more sources
Attenuation and Stability of CHIKV-NoLS, a Live-Attenuated Chikungunya Virus Vaccine Candidate [PDF]
Vaccines, 2018 Our previous investigation of the nucleolar localisation sequence (NoLS) of chikungunya virus (CHIKV) capsid protein demonstrated the role of capsid in CHIKV virulence. Mutating the NoLS of capsid in CHIKV led to the development of a unique live-attenuated CHIKV vaccine candidate, termed CHIKV-NoLS.
Eranga Abeyratne +4 more
openalex +6 more sources
Treatment of Chikungunya Virus (CHIKV) Using Targeted Immunotherapy
, 2021 Chikungunya virus (CHIKV) is the most common mosquito-borne Alphavirus infecting humans worldwide. Up to date, there are no antiviral treatments or vaccines approved to treat or prevent CHIKV for which treatments remain symptomatic based on clinical manifestations.
Fleury Augustin Nsole Biteghe +5 more
openalex +4 more sources
Chikungunya virus (CHIKV) infection: Analytical performance of real-time NASBA assay [PDF]
International Journal of Infectious Diseases, 2010 n ...
Giada Rossini +5 more
openalex +3 more sources
Journal of the Pakistan Medical Association, 2021 Objective: The present study aims to outline the genotype of circulating CHIKV strains in Pakistan and their phylogenetic analysis Methods: The study is being conducted at Armed Forces Institute of Pathology after the approval by Institutional Review Board. The study was conducted during the period of Aug 2016 to Sep 2017.
Humaira Aziz Sawal +3 more
openalex +3 more sources
EPH15 Transmission Dynamics and Vaccination Strategies for Chikungunya Virus (CHIKV): An Outbreak Simulation Study in Rome, Italy [PDF]
Value in Health, 2023 Giorgia Tiozzo +4 more
openalex +2 more sources
Chikungunya virus (CHIKV) outbreak in Feira de Santana, Bahia: preliminary report [PDF]
Anais do III Simpósio Internacional de Imunobiológicos, 2016 Karen Soares Trinta +7 more
openalex +2 more sources